Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Pereira, Elza A ^a   Ishikawa, Edna Ay ^b   Fontes, Cor Jf ^c  

^a Secretaria Executiva de Estado de Saúde Pública do Pará   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

Author keywords

Adherence; Malaria; Treatment

Indexed keywords

CHLOROQUINE PLUS PRIMAQUINE; CHLOROQUINE; PRIMAQUINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; HEALTH CENTER; HUMAN; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT INFORMATION; PLASMODIUM VIVAX MALARIA; PRESCHOOL CHILD; PRESCRIPTION; RECOMMENDED DRUG DOSE; SCHOOL CHILD; UNSPECIFIED SIDE EFFECT; AGED; ATTITUDE TO HEALTH; BRAZIL; DISEASE TRANSMISSION; MIDDLE AGED; PATHOGENICITY; PLASMODIUM VIVAX; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; STATISTICS;

ADOLESCENT; ADULT; AGED; BRAZIL; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFANT; INTERVIEWS AS TOPIC; MALARIA, VIVAX; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PLASMODIUM VIVAX; PRIMAQUINE; RECURRENCE; YOUNG ADULT;

EID: 83255162704     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-355     Document Type: Article

References (19)

1. Malaria in Brazil: an overview. Oliveira-Ferreira J, Lacerda MV, Brasil P, Ladislau JL, Tauil PL, Daniel-Ribeiro CT, Malar J 2010 9 115 10.1186/1475-2875-9-115 20433744
2. Neglect of Plasmodium vivax malaria. Baird JK, Trends Parasitol 2007 23 533 539 10.1016/j.pt.2007.08.011 17933585 (Pubitemid 350026468)
3. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Alecrim MGC, Alecrim W, Macedo V, Rev Soc Bras Med Trop 1999 32 67 68 9927829 (Pubitemid 29006271)
4. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Santana-Filho FS, Arcanjo ARL, Chehuan YM, Costa MRC, Martinez-Espinosa FE, Vieira JL, Barbosa MG, Alecrim WD, Alecrim MG, Emerg Infect Dis 2007 13 1125 1126 18214203 (Pubitemid 47048104)
5. How do patients use antimalarial drugs? A review of the evidence. Yeung S, White NJ, Trop Med Int Health 2005 10 121 138 10.1111/j.1365-3156.2004.01364. x 15679555 (Pubitemid 40269162)
6. Self-reported compliance with malaria treatment and occurrence of malaria during follow-up in a Brazilian Amazon population. Duarte EC, Gyorkos TW, Trop Med Int Health 2003 8 518 524 10.1046/j.1365-3156.2003.01042.x 12791057 (Pubitemid 36724016)
7. Interventions to improve the use of antimalarials in south-east Asia: an overview. Gomes M, Wayling S, Pang L, Bull World Health Organ 1998 76 9 19 9763718 (Pubitemid 128685309)
8. Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon. Grietens KP, Soto V, Erhart A, Ribera JM, Toomer E, Tenorio A, Montalvo TG, Rodriguez H, Cuentas AL, D'Alessandro U, Gamboa D, Am J Trop Med Hyg 2010 82 1017 1023 10.4269/ajtmh.2010.09-0521 20519594
9. Compliance with artesunate and quinine plus tetracycline treatment of uncomplicated falciparum malaria in Thailand. Fungladda W, Honrado ER, Thimasarn K, Kitayaporn D, Karbwang J, Kamolratanakul P, Masngammueng R, Bull World Health Organ 1998 76 59 66 9763724 (Pubitemid 128685315)
10. The role of communication between clients and health care providers: implications for adherence to malaria treatment in rural Gambia. Conteh L, Stevens W, Wiseman V, Trop Med Int Health 2007 12 382 391 10.1111/j.1365-3156. 2006.01806.x 17313510 (Pubitemid 46280636)
11. Usaid: Amazon Malaria Initiative. http://www.usaidami.org
12. Factores asociados con el incumplimiento del tratamiento antipalúdico en pacientes ecuatorianos. Yépez MC, Zambrano D, Carrasco F, Yépez RF, Rev Cub Med Trop 2000 52 81 89
13. Barriers to prompt and effective treatment of malaria in northern Sri Lanka. Reilley B, Abeyasinghe R, Pakianathar MV, Trop Med Int Health 2002 7 744 749 10.1046/j.1365-3156.2002.00919.x 12225504
14. Ensayo clínico del tratamiento de la malaria vivax con esquema acortado de primaquine comparado con el esquema tradicional. Solari-Soto L, Soto-Tarazona A, Mendoza-Requena D, Llanos-Cuentas A, Rev Soc Peru Med Interna 2002 15 197 199
15. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy. Goller JL, Jolley D, Ringwald P, Biggs BA, Am J Trop Med Hyg 2007 76 203 207 17297026 (Pubitemid 351627764)
16. Knowledge of Malaria, Risk Perception, and Compliance with Prophylaxis and Personal and Environmental Preventive Measures in Travelers Exiting Zimbabwe from Harare and Victoria Falls International Airport. Laver SM, Wetzels J, Behrens RH, J Travel Med 2001 8 298 303 11726294 (Pubitemid 34000944)
17. Comprehensive community effectiveness of health care. A study of malaria treatment in children and adults in rural Burkina Faso. Krause G, Sauerborn R, Ann Trop Paediatr 2000 20 273 282 11219164
18. Potential contribution of prescription practices to the emergence and spread of chloroquine resistance in South-West Nigeria: caution in the use of artemisinin combination therapy. Gbotosho GO, Happi CT, Ganiyu A, Ogundahunsi OA, Sowunmi A, Oduola AM, Malar J 2009 8 313 10.1186/1475-2875-8-313 20042098
19. Diagnástico das Condições de Saúde de uma comunidade Garimpeira na Região do Rio Tapajás, Itaituba, Pará, Brasil, 1992. Santos EO, Loureiro EC, Jesus IM, Brabo E, Silva RS, Soares MC, Camara VM, Souza MR, Branches F, Cad Saude Publica 1995 11 212 225 10.1590/S0102-311X1995000200005 14528328